Inventor · disambiguated record
Jennifer Nelson
Also filed as: NELSON JENNIFER · NELSON JENNIFER A
19 granted patents·20 pending applications·188 citations·filing 2010–2025
94Inventor score
Files withMODERNATX INC15FLAGSHIP PIONEERING INNOVATIONS VI LLC9BASF SE6SCHAUB ROBERT2FLAGSHIP PIONEERING INC1
Top patents by PatentIndex Score
39 records- 0198US10653712B2High purity RNA compositions and methods for preparation thereofMODERNATX INC·Filed 2018·Granted May 19, 2020·73 cites·18 claims
- 0297US10072057B2Alternative nucleic acid molecules containing reduced uracil content and uses thereofMODERNATX INC·Filed 2017·Granted Sep 11, 2018·31 cites·21 claims
- 0397US9751925B2Alternative nucleic acid molecules containing reduced uracil content and uses thereofMODERNATX INC·Filed 2015·Granted Sep 5, 2017·32 cites·29 claims
- 0495US11202793B2High purity RNA compositions and methods for preparation thereofMODERNATX INC·Filed 2017·Granted Dec 21, 2021·15 cites·23 claims
- 0594US11634442B2Methods for the purification of L-glufosinateBASF SE·Filed 2018·Granted Apr 25, 2023·5 cites·4 claims
- 0693US12338474B2Compositions and methods for producing circular polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Jun 24, 2025·1 cites·23 claims
- 0792US12246029B2High purity RNA compositions and methods for preparation thereofMODERNATX INC·Filed 2021·Granted Mar 11, 2025·1 cites·34 claims
- 0892US12233084B2High purity RNA compositions and methods for preparation thereofMODERNATX INC·Filed 2021·Granted Feb 25, 2025·1 cites·36 claims
- 0989US10407683B2Circular polynucleotidesMODERNATX INC·Filed 2015·Granted Sep 10, 2019·9 cites·21 claims
- 1088US2024247013A1Methods for the purification of l-glufosinateBASF SE·Filed 2024·Application pending·0 cites
- 1188US2024270770A1Methods for the purification of l-glufosinateBASF SE·Filed 2024·Application pending·0 cites
- 1287US11976089B2Methods for the purification of L-glufosinateBASF SE·Filed 2023·Granted May 7, 2024·0 cites·2 claims
- 1387US11897909B2Methods for the purification of L-glufosinateBASF SE·Filed 2023·Granted Feb 13, 2024·0 cites·4 claims
- 1487US11897908B2Methods for the purification of L-glufosinateBASF SE·Filed 2023·Granted Feb 13, 2024·0 cites·4 claims
- 1585US11348481B2Simulator systems and methodsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2018·Granted May 31, 2022·5 cites·27 claims
- 1683US8598327B2Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeuticsSCHAUB ROBERT·Filed 2011·Granted Dec 3, 2013·10 cites·19 claims
- 1779US2025275999A1High purity rna compositions and methods for preparation thereofMODERNATX INC·Filed 2025·Application pending·0 cites
- 1877US2025186624A1Polynucleotides containing a stabilizing tail regionMODERNATX INC·Filed 2024·Application pending·0 cites
- 1976US8252913B2Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeuticsSCHAUB ROBERT G·Filed 2010·Granted Aug 28, 2012·4 cites·36 claims
- 2076US2023416324A1Alternative nucleic acid molecules containing reduced uracil content and uses thereofMODERNA TX INC·Filed 2022·Application pending·0 cites
- 2175US11434486B2Polynucleotides containing a morpholino linkerMODERNATX INC·Filed 2016·Granted Sep 6, 2022·1 cites·23 claims
- 2272US12071620B2Polynucleotides containing a morpholino linkerMODERNATX INC·Filed 2022·Granted Aug 27, 2024·0 cites·20 claims
- 2371US2025277224A1Compositions and methods for producing circular polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2025·Application pending·0 cites
- 2468US2019092828A1Alternative nucleic acid molecules containing reduced uracil content and uses thereofMODERNATX INC·Filed 2018·Application pending·0 cites
- 2566US2025032604A1Immunogenic compositions and their usesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 2666US2025368688A1Varicella-zoster virus immunogen compositions and their usesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 2763US2025352638A1Coronavirus immunogen compositions and their usesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 2861US2024401024A1Methods for enrichment of circular rna under denaturing conditionsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 2959US12109274B2Polynucleotides containing a stabilizing tail regionMODERNATX INC·Filed 2016·Granted Oct 8, 2024·0 cites·9 claims
- 3056US2024009298A1Immunogenic compositions and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
- 3154US2023181722A1Coronavirus antigen compositions and their usesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
- 3254US2023193311A1Immunogenic compositions and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
- 3354US2022298516A1Compositions and methods for delivery of nucleic acidsMODERNATX INC·Filed 2019·Application pending·0 cites
- 3451US2023203192A1Compositions and methods for producing human polyclonal antibodiesFLAGSHIP PIONEERING INC·Filed 2021·Application pending·0 cites
- 3550US8461318B2Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder thereapeuticsSCHAUB ROBERT·Filed 2011·Granted Jun 11, 2013·0 cites·1 claims
- 3644US2020362382A1Methods of preparing modified rnaMODERNATX INC·Filed 2018·Application pending·0 cites
- 3737US2020270547A1Microbial culture, composition, use and methodNOVOZYMES AS·Filed 2017·Application pending·0 cites
- 3835US2017204152A1Chimeric polynucleotidesMODERNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3932US2017166894A1Aptamers for topical deliveryGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jennifer Nelson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →